No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
SR240517P55000
- 0.60
- 0.000.00%
15min DelayTrading Mar 21 14:11 ET
0.00High0.00Low
0.00Open0.60Pre Close0 Volume2 Open Interest55.00Strike Price0.00Turnover125.70%IV-12.43%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier3DDays to Expiry0.60Time Value100Contract SizeAmericanOptions Type-0.1461Delta0.0304Gamma103.54Leverage Ratio-0.2497Theta-0.0009Rho-15.13Eff Leverage0.0138Vega
Intraday
- 5D
- 1D
News
Spire (SR) Receives a Rating Update From a Top Analyst
Spire Healthcare Shareholders Approve All Resolutions
Spire Healthcare Reiterates FY24 Guidance
Spire Healthcare Group (SPI.L) affirmed its outlook for 2024 as trading has remained strong since its 2023 results announcement in February, according to its trading update published Thursday. The UK
Spire Healthcare Reports Continued Strong Performance
Express News | NYSE Order Imbalance 93297.0 Shares on Sell Side
Spire Second Quarter 2024 Earnings: Misses Expectations
Comments
The market's past overvaluation of the stock led to disappointment despite EPS improvement. Further research could explain the price drop. Good stocks can drop, but business fundamentals need to improve to generate interest. Investors are advised to ensure they're buying a high quality business.
Spire (NYSE:SR) Shareholders Have Endured a 10% Loss From Investing in the Stock Five Years AgoThe low ROE, despite significant debt, is disappointing. High debt levels heighten risk and limit future options, thus good returns are expected. High ROE with minimal debt usually indicates a quality business.
1
Spire's president and CEO, Steve Lindsey, expressed confidence in Doyle's leadership and his extensive experience in capital deployment, regulatory strategy, and operational leadership, which aligns with Spire's 10-year plan focusing on system investments and continuous operational improvement.
Spire's inferior earnings outlook can lead to the argument that its high P/E ratio isn't justified. With prevailing conditions, its prices are questionable. Investors seem immune to bearish views from analysts.
Despite insider share purchases and improving dividends at Spire, market confidence is dwindling. Future earnings and clear growth indications will be decisive for stabilizing the stock price, amidst spotted warning signs.
Read more